|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01355 BIOSYSEN
Nominal 
0.170 +0.016 (+10.390%) | 2026/06 - Interim HKD(K$) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Net Cash from / (used in) Operating Activities | -- | (32,693) | 24,268 | 35,160 | 9,348 |
| Net Cash from / (used in) Investing Activities | -- | (31,814) | (250) | (644) | (2,928) |
| Net Cash from / (used in) Financing Activities | -- | 52,988 | (11,978) | (34,944) | (19,009) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (11,519) | 12,040 | (428) | (12,589) |
| Cash & Cash Equivalents at beginning of period | -- | 13,857 | 2,214 | 2,434 | 14,296 |
| Effect of Foreign Exchange Rate Changes | -- | 105 | (397) | 208 | 727 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 2,443 | 13,857 | 2,214 | 2,434 |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 21,149 |
| %Change | -- |
| EPS / (LPS) | HKD 0.015 |
| NBV Per Share ($) | HKD -0.010 |